Hyperbaric Oxygen Treatment Attenuates Renal... (2026 study) Skip to main content
Study Undersea Hyperb Med 2026

Hyperbaric Oxygen Treatment Attenuates Renal Ischemia/Reperfusion Injury in Rats

Yang B, Liu J, Ding L, Li M, Fu X, Li Z, et al., Undersea Hyperb Med, 2026

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated if hyperbaric oxygen treatment could reduce kidney damage caused by a lack of blood flow and subsequent reperfusion in rats.

What They Found

This animal model study found that hyperbaric oxygen treatment significantly reduced kidney injury in rats, as evidenced by lower blood urea nitrogen and creatinine levels (p < 0.05). Rats receiving two sessions of hyperbaric oxygen (90 minutes at 1.6 ATA) showed improved kidney structure and reduced activation of necroptosis, a type of cell death. The treatment also lessened severe tubular damage and neutrophil infiltration seen in untreated rats with kidney injury.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

A limitation of this study is that it was conducted in rats, and these findings may not directly translate to human patients.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Decompression Sickness
Source Pubmed
PubMed ID 42365949
Year Published 2026
Journal Undersea Hyperb Med
MeSH Terms Animals; Hyperbaric Oxygenation; Reperfusion Injury; Rats, Sprague-Dawley; Blood Urea Nitrogen; Creatinine; Acute Kidney Injury; Male; Kidney; Rats; Necroptosis; Disease Models, Animal; Neutrophil Infiltration; Diving and Hyperbaric Medicine; Receptor-Interacting Protein Serine-Threonine Kinases

Cite This Study

Share

This study relates to Decompression Sickness. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: July 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology